Savior Lifetec Corporation

Taipei Exchange 4167.TWO

Savior Lifetec Corporation EBITDA Margin for the year ending December 31, 2023: 20.91%

Savior Lifetec Corporation EBITDA Margin is 20.91% for the year ending December 31, 2023, a 1.51% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Savior Lifetec Corporation EBITDA Margin for the year ending December 31, 2022 was 20.60%, a 36.40% change year over year.
  • Savior Lifetec Corporation EBITDA Margin for the year ending December 31, 2021 was 15.10%, a -45.75% change year over year.
  • Savior Lifetec Corporation EBITDA Margin for the year ending December 31, 2020 was 27.84%, a 48.32% change year over year.
  • Savior Lifetec Corporation EBITDA Margin for the year ending December 31, 2019 was 18.77%, a 253.03% change year over year.
Key data
Date EBITDA Margin EBIT Margin Depreciation and Amortization EBIT
Market news
Loading...
SV Wall Street
Taipei Exchange: 4167.TWO

Savior Lifetec Corporation

Description

Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

Similar companies

4147.TWO

TaiMed Biologics Inc.

USD 2.60

NA

4162.TWO

PharmaEngine, Inc.

USD 3.03

NA

4157.TWO

TaiGen Biopharmaceuticals Holdings Limited

USD 0.34

NA

4192.TWO

SynCore Biotechnology Co.,Ltd

USD 1.06

NA

StockViz Staff

February 4, 2025

Any question? Send us an email